These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29035388)

  • 41. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
    Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
    Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
    Baldassarre T; Truesdell P; Craig AW
    Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
    Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
    Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
    Yu T; Cho BJ; Choi EJ; Park JM; Kim DH; Kim IA
    Oncotarget; 2016 Nov; 7(48):79089-79100. PubMed ID: 27738326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network.
    Liang Y; Lu Q; Li W; Zhang D; Zhang F; Zou Q; Chen L; Tong Y; Liu M; Wang S; Li W; Ren X; Xu P; Yang Z; Dong S; Zhang B; Huang Y; Li D; Wang H; Yu W
    Nucleic Acids Res; 2021 Sep; 49(15):8556-8572. PubMed ID: 34329471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
    Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
    Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Lebert A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Sci Rep; 2017 Jul; 7(1):6597. PubMed ID: 28747748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of H3K4me3 and H3K9ac in breast cancer.
    Berger L; Kolben T; Meister S; Kolben TM; Schmoeckel E; Mayr D; Mahner S; Jeschke U; Ditsch N; Beyer S
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2017-2027. PubMed ID: 32468423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LILRB1 Intron 1 Has a Polymorphic Regulatory Region That Enhances Transcription in NK Cells and Recruits YY1.
    Yu K; Davidson CE; Burshtyn DN
    J Immunol; 2020 Jun; 204(11):3030-3041. PubMed ID: 32321755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
    Avraham A; Cho SS; Uhlmann R; Polak ML; Sandbank J; Karni T; Pappo I; Halperin R; Vaknin Z; Sella A; Sukumar S; Evron E
    PLoS One; 2014; 9(3):e91805. PubMed ID: 24651077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance.
    Perlman BS; Burget N; Zhou Y; Schwartz GW; Petrovic J; Modrusan Z; Faryabi RB
    Nat Commun; 2024 Sep; 15(1):8070. PubMed ID: 39277592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population-dependent Intron Retention and DNA Methylation in Breast Cancer.
    Kim D; Shivakumar M; Han S; Sinclair MS; Lee YJ; Zheng Y; Olopade OI; Kim D; Lee Y
    Mol Cancer Res; 2018 Mar; 16(3):461-469. PubMed ID: 29330282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcription factor AP-2 gamma affects porcine early embryo development by regulating epigenetic modification.
    Zhang D; Wu D; Zhang S; Zhang M; Zhou Y; An X; Li Q; Li Z
    Reprod Biomed Online; 2024 Oct; 49(4):103772. PubMed ID: 38749801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of enhancer RNAs in epigenetic regulation of gene expression.
    Rahnamoun H; Orozco P; Lauberth SM
    Transcription; 2020 Feb; 11(1):19-25. PubMed ID: 31823686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequence based prediction of enhancer regions from DNA random walk.
    Singh AP; Mishra S; Jabin S
    Sci Rep; 2018 Oct; 8(1):15912. PubMed ID: 30374023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity.
    Zheng JY; Wang CY; Gao C; Xiao Q; Huang CW; Wu M; Li LY
    Cell Death Dis; 2021 Apr; 12(4):364. PubMed ID: 33824309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knocking Out Enhancers to Enhance Epigenetic Research.
    Duester G
    Trends Genet; 2019 Feb; 35(2):89. PubMed ID: 30466730
    [No Abstract]   [Full Text] [Related]  

  • 59. Fragment of intron 5.2 of the human RUNX1 gene important for transcription activation is neither enhancer nor MAR-element.
    Markova EN; Razin SV; Kantidze OL
    Dokl Biochem Biophys; 2012; 442():26-9. PubMed ID: 22419089
    [No Abstract]   [Full Text] [Related]  

  • 60. ASO Author Reflections: Genetic Heterogeneity in HER2-Low Breast Cancers Reflects Different Treatment Responses.
    Yang L
    Ann Surg Oncol; 2023 Sep; 30(9):5663-5664. PubMed ID: 37036588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.